Participations à des congrès et colloques internationaux (17)
  1. 9. Levet, V., Rosiere, R., Amighi, K., & Wauthoz, N. (2016). Local and systemic pharmacokinetic evaluation of immediate-release and controlled-release cisplatin dry powders for inhalation against lung cancer. Poster présenté à la conférence Drug delivery to the lungs (27: December 6-9th 2016: Edinburgh, Scotland).
  2. 10. Van Woensel, M., Wauthoz, N., Rosiere, R., Mathieu, V., Kiss, R., Lefranc, F., Steelant, B., Van Gool, S. W., Mathivet, T., Gerhardt, H., & Amighi, K. (2016). Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration. Paper session presented at Respiratory Drug Delivery (2016: 17-21/04/2016: Phoenix (Arizona)).
  3. 11. Van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., Mathivet, T., & De Vleeschouwer, S. (2015). Intranasal delivery of anti-Galectin-1 formulation to increase the efficiency of chemo- and immunotherapy for glioblastoma. Poster présenté à la conférence European Conference on Pharmaceutics (1st: 13 and 14/04/2015: Reims, France).
  4. 12. Rosiere, R., Van Woensel, M., Langer, I., Mathieu, V., Amighi, K., & Wauthoz, N. (2015). Nanomicelle-based dry powders for inhalation for targeted delivery to lung cancer cells: in vitro evaluation and in vivo local pulmonary tolerance on healthy mice. Poster présenté à la conférence European Conference on Pharmaceutics (1st: 13 and 14/04/2015: Reims, France).
  5. 13. Rosiere, R., Van Antwerpen, P., Gelbcke, M., Amighi, K., & Wauthoz, N. (2014). Development of nanoparticle formulations composed by new folate receptor-targeted excipients and temozolomide for the lung cancers therapy by inhalation. Poster présenté à la conférence Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (9th: 31/03/2014-03/04/2014: Lisbonne, Portugal).
  6. 14. Van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., Mathivet, T., & De Vleeschouwer, S. (2014). Intranasal delivery of anti-Galectin-1 formulation to increase the efficiency of chemo- and immunotherapy for glioblastoma. Poster présenté à la conférence Belgian Society of Neurosurgery (29/03/2014: Brussels).
  7. 15. Rosiere, R., Wauthoz, N., Gelbcke, M., Van Antwerpen, P., & Amighi, K. (2013). Development of new inhalable formulation for the lung cancers therapy. Paper session presented at Journée des Doctorants de sciences biomédicales, dentaires, sciences médicales et pharmaceutiques (13: 19/12/2013: Erasme).
  8. 16. Rosiere, R., Wauthoz, N., Gelbcke, M., Van Antwerpen, P., & Amighi, K. (2013). Development of new inhalable formulation for the lung cancers therapy. Paper session presented at Forum des sciences pharmaceutiques de la SBSP (17: 17-18/10/2013: Spa).
  9. 17. Duret, C., Wauthoz, N., Rosiere, R., Merlos, R., Sebti, T., Vanderbist, F., & Amighi, K. (2013). A new Inhaled Itraconazole Solid Dispersion for Inhalation against Invasive Pulmonary Aspergillosis. Poster présenté à la conférence Innovation in Drug Delivery (3 rd: 22-25/09/2013: Pise - Italie).
    10.   Brevets (4)
  10. 1. Amighi, K., Wauthoz, N., & Rosiere, R. (2018). Dry powder inhalation formulation and its use for the therapeutic treatment of lungs.
  11. 2. Amighi, K., Wauthoz, N., & Rosiere, R. (2018). Kit for inhaled chemotherapy, and treatment of lung cancer with said kit.
  12. 3. Van Woensel, M., Wauthoz, N., Rosiere, R., Mathieu, V., Kiss, R., Lefranc, F., Steelant, B., Van Gool, S. W., Mathivet, T., Gerhardt, H., Amighi, K., & De Vleeschouwer, S. (2015). Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration: patent application GB1519841.9 - PCT/EP2016/078547 & WO2017/089392A1.
    13. << Précédent 1 2 3 4 5 Suivant >>